Unrelated Donor Hematopoietic Stem Cell Transplantation (Hsct) With Myeloablative Preparative Regimens For The Treatment Of De Novo Acute Myelogenous Leukemia (Aml) In Patients Older Than 44 Years.
BLOOD（2003）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要